Menu

Image of the Day: Frog Leaps Away from Extinction 

A once critically endangered species of leaf frog has made a comeback. 

Jan 3, 2018
The Scientist Staff, The Scientist Staff

The black-eyed leaf frog, Agalychnis moreletii, in its native habitat in GuatemalaROBIN MOORE, GLOBAL WILDLIFE CONSERVATION The black-eyed leaf frog (Agalychnis moreletii) was once listed as critically endangered on the IUCN Red List of Threatened Species, which is often the last step before complete extinction. But 13 years later, in a reevaluation of extinction risk of amphibians—supported by Global Wildlife Conservation—researchers found that the frog has made a comeback. They found the animal in historical as well as new locations in high abundances throughout its native range from Mexico to Honduras, and re-classified the frog as a species of least concern on the IUCN Red List.  

The animal was among 40 species in the evaluation whose extinction risk was downgraded. However, researchers found 23 other species to be at a higher risk of extinction than previously thought. This includes the Rio Cosnipata robber frog (Pristimantis cosnipatae), a Peruvian species that was last seen in 1999 and is considered possibly extinct. 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.